TNF and psoriasis: TNF inhibitors (TNFi) have a well-established efficacy and safety profile, making them a reliable option for psoriasis and psoriatic arthritis; however, they carry risks such as tuberculosis reactivation, loss of efficacy due to anti-drug antibodies, and potential paradoxical psoriasis.